pf-06463922 and Cholangiocarcinoma

pf-06463922 has been researched along with Cholangiocarcinoma* in 1 studies

Other Studies

1 other study(ies) available for pf-06463922 and Cholangiocarcinoma

Article	Year
Cholangiocarcinoma with STRN-ALK translocation treated with ALK inhibitors. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2021, Volume: 53, Issue:12 Topics: Aminopyridines; Anaplastic Lymphoma Kinase; Bile Duct Neoplasms; Calmodulin-Binding Proteins; Cholangiocarcinoma; Female; Humans; Lactams; Membrane Proteins; Nerve Tissue Proteins; Pyrazoles; Receptor Protein-Tyrosine Kinases; Translocation, Genetic	2021

Article

Year

Cholangiocarcinoma with STRN-ALK translocation treated with ALK inhibitors.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2021, Volume: 53, Issue:12

Topics: Aminopyridines; Anaplastic Lymphoma Kinase; Bile Duct Neoplasms; Calmodulin-Binding Proteins; Cholangiocarcinoma; Female; Humans; Lactams; Membrane Proteins; Nerve Tissue Proteins; Pyrazoles; Receptor Protein-Tyrosine Kinases; Translocation, Genetic

2021